美国 · SEC FORM 4
Bionano Genomics, Inc.
BNGO · Nasdaq · CIK 0001411690 · Healthcare · Medical Instruments & Supplies
内部人信号
1 位买方 · 2 条买入交易行 · $9.7K 买入总额
为什么有这个信号？
评分构成
每条进度条表示其对当前分数的贡献；权重和公式保持不变。
哪些因素限制了当前分数？
- ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
- ⚠ Purchase size is modest relative to the model scale
- ⚠ 角色得分低 · 买入者中职位最高的是：Interim Chief Executive（CEO、董事长和持股 10% 以上的股东得分最低）
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度与集中度
Roles in the peak window: Interim Chief Executive. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
最新留档分数
- 36.8
- 36.7
- 36.7
- 36.5
- 36.4
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- +20.0%
- 3M
- +23.1%
- 6M
- +27.4%
- 12M
- -27.3%
波动率与流动性
- 波动率
- 94.9%
- Beta
- —
- 平均每日成交额
- USD 1.3M
估值
- 市值
- USD 17.0M
- P/E
- —
基本面
- 利润率
- -92.6%
- ROE
- -59.4%
- 细分行业
- Medical Instruments & Supplies
市场数据
价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件：市值, 利润率, ROE · 财年截止日：2025-12-31 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期：2026-08-06 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 2,035,020
- 上期报告
- 1,144,194
- 日均成交量
- 978,648
- 回补天数
- 2.1
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-04 | Luderer Albert | 买入 (P) | Common Stock | 4,000 | USD 1.21 | USD 4,840 | SEC 申报 ↗ |
| 2026-08-21 | Luderer Albert | 买入 (P) | Common Stock | 4,000 | USD 1.22 | USD 4,880 | SEC 申报 ↗ |
| 2023-06-13 | Mamuszka Hannah | 买入 (P) | Common Stock | 65,789 | USD 0.76 | USD 50,000 | SEC 申报 ↗ |
| 2023-05-16 | Holmlin R. Erik | 买入 (P) | Common Stock | 15,000 | USD 0.64 | USD 9,600 | SEC 申报 ↗ |
| 2023-05-12 | Stewart Christopher P. | 买入 (P) | Common Stock | 50,000 | USD 0.67 | USD 33,500 | SEC 申报 ↗ |
| 2022-05-16 | BARKER DAVID L | 买入 (P) | Common Stock | 10,000 | USD 1.60 | USD 16,000 | SEC 申报 ↗ |
| 2021-11-29 | Holmlin R. Erik | 买入 (P) | Common Stock | 5,025 | USD 3.99 | USD 20,048 | SEC 申报 ↗ |
Form 4 申报证据
11 transaction lines in the latest 365-day window; 65 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-04 | Luderer Albert | 买入 (P) | Common Stock | 4,000 | USD 1.21 | USD 4,840 | SEC 申报 ↗ |
| 2026-08-21 | Luderer Albert | 买入 (P) | Common Stock | 4,000 | USD 1.22 | USD 4,880 | SEC 申报 ↗ |
| 2026-06-03 | OLDAKOWSKI MARK | 代扣税 (F) | Common Stock | 27 | USD 1.30 | USD 35 | SEC 申报 ↗ |
展开近期 Form 4 证据 (11 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-04 | Luderer Albert | 买入 (P) | Common Stock | 4,000 | USD 1.21 | USD 4,840 | SEC 申报 ↗ |
| 2026-08-21 | Luderer Albert | 买入 (P) | Common Stock | 4,000 | USD 1.22 | USD 4,880 | SEC 申报 ↗ |
| 2026-06-03 | OLDAKOWSKI MARK | 代扣税 (F) | Common Stock | 27 | USD 1.30 | USD 35 | SEC 申报 ↗ |
| 2026-06-03 | Dixon Jonathan V. | 代扣税 (F) | Common Stock | 24 | USD 1.30 | USD 31 | SEC 申报 ↗ |
| 2026-06-03 | Chaubey Alka | 代扣税 (F) | Common Stock | 24 | USD 1.30 | USD 31 | SEC 申报 ↗ |
| 2026-06-03 | Adamchak Mark | 代扣税 (F) | Common Stock | 7 | USD 1.30 | USD 9 | SEC 申报 ↗ |
| 2026-02-17 | OLDAKOWSKI MARK | 代扣税 (F) | Common Stock | 20 | USD 1.10 | USD 22 | SEC 申报 ↗ |
| 2026-02-17 | Holmlin R. Erik | 代扣税 (F) | Common Stock | 51 | USD 1.10 | USD 56 | SEC 申报 ↗ |
| 2026-02-17 | Dixon Jonathan V. | 代扣税 (F) | Common Stock | 6 | USD 1.10 | USD 7 | SEC 申报 ↗ |
| 2026-02-17 | Chaubey Alka | 代扣税 (F) | Common Stock | 18 | USD 1.10 | USD 20 | SEC 申报 ↗ |
| 2026-02-17 | Adamchak Mark | 代扣税 (F) | Common Stock | 3 | USD 1.10 | USD 3 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | BNGO |
| CIK | 0001411690 |
| 行业 | Healthcare |
| 细分行业 | Medical Instruments & Supplies Yahoo Finance |
| SEC SIC | 3826 Laboratory Analytical Instruments |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 65 transaction lines from 2020-04-06 to 2026-09-04 9 P purchase lines · 1 S sale lines · 55 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.